Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in IntangiblesChange in IntangiblesChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Biomerica (BMRA) Net Cash Flow (2016 - 2026)

Biomerica's Net Cash Flow history spans 17 years, with the latest figure at -$1.2 million for Q1 2026.

  • On a quarterly basis, Net Cash Flow fell 273.07% to -$1.2 million in Q1 2026 year-over-year; TTM through Feb 2026 was -$1.7 million, a 31.96% increase, with the full-year FY2025 number at -$1.8 million, up 68.2% from a year prior.
  • Net Cash Flow hit -$1.2 million in Q1 2026 for Biomerica, down from -$509000.0 in the prior quarter.
  • Over the last five years, Net Cash Flow for BMRA hit a ceiling of $6.4 million in Q2 2023 and a floor of -$4.2 million in Q2 2022.
  • Historically, Net Cash Flow has averaged -$356659.7 across 5 years, with a median of -$854000.0 in 2023.
  • Biggest five-year swings in Net Cash Flow: skyrocketed 833.68% in 2022 and later tumbled 1115.79% in 2023.
  • Tracing BMRA's Net Cash Flow over 5 years: stood at -$1.0 million in 2022, then grew by 14.6% to -$854000.0 in 2023, then grew by 7.38% to -$791000.0 in 2024, then skyrocketed by 35.65% to -$509000.0 in 2025, then plummeted by 133.6% to -$1.2 million in 2026.
  • Business Quant data shows Net Cash Flow for BMRA at -$1.2 million in Q1 2026, -$509000.0 in Q4 2025, and $652000.0 in Q3 2025.